DME Capital Management, DME Advisors, DME Advisors GP and David Einhorn report beneficial ownership of 12,395,104 shares of Dauch Corporation common stock, representing 5.2% of the outstanding shares.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
DME Capital Management, DME Advisors, DME Advisors GP and David Einhorn report beneficial ownership of 12,395,104 shares of Dauch Corporation common stock, representing 5.2% of the outstanding shares. All reported shares are held in private investment funds and managed accounts for which DME Capital acts as investment advisor or general partner.
The reporting persons state they have shared voting and dispositive power over 12,395,104 shares and no sole voting or dispositive power. The percentage ownership is based on 237,366,732 shares outstanding as of May 5, 2026. Each reporting person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest.
Key Figures
Shares beneficially owned:12,395,104 sharesPercent of class:5.2 %Shares outstanding baseline:237,366,732 shares+3 more
6 metrics
Shares beneficially owned12,395,104 sharesCommon stock of Dauch Corporation reported by the group of reporting persons
Percent of class5.2 %Ownership percentage of Dauch Corporation common stock
Shares outstanding baseline237,366,732 sharesCommon stock outstanding as of May 5, 2026, used to calculate ownership percentage
Shared voting power12,395,104 sharesNumber of shares over which the reporting persons have shared power to vote
Sole voting power0 sharesNumber of shares over which the reporting persons have sole power to vote
Shared dispositive power12,395,104 sharesNumber of shares over which the reporting persons have shared power to dispose
"shall not be construed as an admission that any of the Reporting Persons is for the purposes of Section 13(d) or 13(g) ... the beneficial owner"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
shared voting powerregulatory
"Shared Voting Power 12,395,104.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerregulatory
"Shared Dispositive Power 12,395,104.00"
pecuniary interestfinancial
"disclaims all such beneficial ownership except to the extent of its pecuniary interest in any shares"
Schedule 13Gregulatory
"The filing of this shall not be construed as an admission ... under Section 13(d) or 13(g)"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Dauch Corporation (DCH) is reported by DME Capital and David Einhorn?
DME Capital entities and David Einhorn report beneficial ownership of 12,395,104 shares of Dauch Corporation common stock, representing 5.2% of the company’s outstanding shares based on 237,366,732 shares outstanding as of May 5, 2026.
How much voting power do the reporting persons have in Dauch Corporation (DCH)?
The reporting persons state they have 0 shares with sole voting power and 12,395,104 shares with shared voting power. They also report the same number of shares with shared dispositive power and none with sole dispositive power.
Who are the reporting persons in the Dauch Corporation (DCH) Schedule 13G?
The filing is made by DME Capital Management, LP, DME Advisors, LP, DME Advisors GP, LLC, and David Einhorn. The shares are held in private investment funds and managed accounts for which DME Capital acts as investment advisor or general partner.
What percentage of Dauch Corporation (DCH) does David Einhorn’s group beneficially own?
The reporting group, including David Einhorn, reports beneficial ownership of 5.2% of Dauch Corporation’s common stock, corresponding to 12,395,104 shares, calculated using the company’s reported 237,366,732 shares outstanding as of May 5, 2026.
Do DME Capital and David Einhorn admit full beneficial ownership of their Dauch (DCH) shares?
No. The reporting persons expressly disclaim beneficial ownership of the reported shares except to the extent of any pecuniary interest. The shares are held for private funds and managed accounts advised by DME Capital entities.
Where are DME Capital and David Einhorn’s Dauch (DCH) investment operations based?
The principal business office for the reporting entities and David Einhorn in this context is listed as 140 East 45th Street, 24th Floor, New York, New York 10017, with the entities organized in Delaware and Einhorn a U.S. citizen.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Dauch Corporation
(Name of Issuer)
Common Stock
(Title of Class of Securities)
024061103
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
024061103
1
Names of Reporting Persons
DME Capital Management, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
10,936,304.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
10,936,304.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
10,936,304.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.6 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
024061103
1
Names of Reporting Persons
DME Advisors, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,458,800.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,458,800.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,458,800.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.6 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
024061103
1
Names of Reporting Persons
DME Advisors GP, L.L.C.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
12,395,104.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
12,395,104.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
12,395,104.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.2 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
CUSIP Number(s):
024061103
1
Names of Reporting Persons
EINHORN DAVID
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
12,395,104.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
12,395,104.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
12,395,104.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.2 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Dauch Corporation
(b)
Address of issuer's principal executive offices:
One Dauch Drive, Detroit, Montana, 482111
Item 2.
(a)
Name of person filing:
This Schedule 13G relating to the common stock, par value $0.01 per share ("Common Stock") of Dauch Corporation, a Delaware corporation (the "Company" or the "Issuer"), is being filed by DME Capital Management, LP, a Delaware limited partnership ("DME CM"), DME Advisors, LP, a Delaware limited partnership ("DME Advisors"), and DME Advisors GP, LLC, a Delaware limited liability company ("DME GP" and together with DME CM and DME Advisors, "DME Capital"), and Mr. David Einhorn, the principal of DME Capital (collectively with DME Capital, the "Reporting Persons").
This Schedule 13G relates to Common Stock of the Issuer held by DME Capital for the account of private investment funds and managed accounts (the "DME Accounts") for which DME Capital acts as investment advisor (or general partner of the investment advisor) and with respect to which Mr. Einhorn may be deemed to have indirect investment and/or voting power as the principal of DME Capital and other affiliated entities. DME GP is the general partner of DME CM and DME Advisors.
The filing of this Schedule 13G shall not be construed as an admission that any of the Reporting Persons is for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, the beneficial owner of any of the Common Shares reported herein. Pursuant to Rule 13d-4, each of the Reporting Persons disclaims all such beneficial ownership except to the extent of its pecuniary interest in any shares of Common Stock, if applicable.
(b)
Address or principal business office or, if none, residence:
140 East 45th Street, 24th Floor, New York, New York 10017
(c)
Citizenship:
DME CM is a limited partnership organized under the laws of the State of Delaware.
DME Advisors is a limited partnership organized under the laws of the State of Delaware.
DME GP is a limited liability company organized under the laws of the State of Delaware.
David Einhorn is a United States citizen.
(d)
Title of class of securities:
Common Stock
(e)
CUSIP Number(s):
024061103
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
12,395,104 shares
(b)
Percent of class:
5.2 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0 shares
(ii) Shared power to vote or to direct the vote:
12,395,104 shares
(iii) Sole power to dispose or to direct the disposition of:
0 shares
(iv) Shared power to dispose or to direct the disposition of:
12,395,104 shares
The percentages reported herein are calculated on the basis of the Company's statement in the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, as filed with the Securities and Exchange Commission on May 8, 2026, that there were 237,366,732 shares of Common Stock outstanding as of May 5, 2026.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
DME Capital Management, LP
Signature:
/s/ Daniel Roitman
Name/Title:
DME Advisors GP, LLC, its General Partner, by Daniel Roitman/Chief Operating Officer
Date:
08/14/2026
DME Advisors, LP
Signature:
/s/ Daniel Roitman
Name/Title:
DME Advisors GP, LLC, its General Partner, by Daniel Roitman/Chief Operating Officer
Date:
08/14/2026
DME Advisors GP, L.L.C.
Signature:
/s/ Daniel Roitman
Name/Title:
Daniel Roitman/Chief Operating Officer
Date:
08/14/2026
EINHORN DAVID
Signature:
/s/ Daniel Roitman
Name/Title:
Daniel Roitman, on behalf of David Einhorn
Date:
08/14/2026
Comments accompanying signature: Comments accompanying signature: * The Power of Attorney executed by David Einhorn, authorizing the signatory to sign and file Schedule 13G on David Einhorn's behalf, filed as Exhibit 99.1 to the Schedule 13D filed with the Securities and Exchange Commission on August 29, 2019 by the Reporting Persons with respect to the common units of CONSOL Coal Resources, is hereby incorporated by reference.
Exhibit Information
99.1 Joint Filing Agreement by and among the Reporting Persons.
